Inventor · disambiguated record
Nicholas Gale
Also filed as: GALE NICHOLAS · GALE NICHOLAS W
5 granted patents·8 pending applications·75 citations·filing 1994–2016
79Inventor score
Top patents by PatentIndex Score
13 records- 0194US8048418B2Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonistsREGENERON PHARMA·Filed 2009·Granted Nov 1, 2011·34 cites·6 claims
- 0268US6958140B2Methods of imaging and targeting vasculatureREGENERON PHARMA·Filed 2002·Granted Oct 25, 2005·1 cites·9 claims
- 0363US7008781B1Method of enhancing the biological activity of ligandsREGENERON PHARMA·Filed 1999·Granted Mar 7, 2006·16 cites·15 claims
- 0462US5747033AMethod of enhancing the biological activity of Eph family ligandsREGENERON PHARMA·Filed 1994·Granted May 5, 1998·24 cites·6 claims
- 0562US2009271884A1ES Cell-Derived Mice From Diploid Host Embryo InjectionREGENERON PHARMA·Filed 2009·Application pending·0 cites
- 0659US2006014204A1Methods of inducing formation of functional and organized lymphatic vesselsGALE NICHOLAS W·Filed 2005·Application pending·0 cites
- 0757US2004023880A1Methods of inducing formation of functional and organized lymphatic vesselsFiled 2003·Application pending·0 cites
- 0851US2016316728A1ES Cell-Derived Mice From Diploid Host Embryo InjectionREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 0948US2003215918A1Biologically active Eph family ligandsFiled 2003·Application pending·0 cites
- 1047US2003084468A1Methods of expressing transgenesFiled 2002·Application pending·0 cites
- 1147US2008107648A1Therapeutic methods for inhibiting tumor growth with DII4 antagonistsREGENERON PHARMA·Filed 2006·Application pending·0 cites
- 1241US2006134121A1DII4 antagonists, assays, and therapeutic methods thereofTHURSTON GAVIN·Filed 2005·Application pending·0 cites
- 1331US6602683B1Biologically active Eph family ligandsREGENERON PHARMA·Filed 1996·Granted Aug 5, 2003·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas Gale files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →